Tusamitamab Ravtansin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

French pharmaceuticals giant Sanofi on Thursday said it would be halting development of a promising cancer treatment after the cutting-edge candidate failed.

France generalUnited statesTusamitamab ravtansinDietmar bergerTusamitamab ravtansineArticle normalCancer drugsHealthcare life sciencesSpecialized drugs medicationsNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingPolitical general newsChemotherapy radiotherapy immunotherapy